Mar 02, 2021 / 05:50PM GMT
Kenneth Charles Cacciatore - Cowen and Company, LLC, Research Division - MD & Senior Research Analyst
Great. Thanks, everyone, for joining us. Thanks, Bruce and Justin and Robert and Kim. We really appreciate you taking the time with us this afternoon. I'm joined by Stacy and Georgi as well.
Bruce, like a lot of things, I usually tend to go on many ramps when I introduce the companies. And in your case, I have a little bit of a story. But the story, I think, will make sense. It was the morning that the announcement was made about GW. And of course, Phil Nadeau, my dear friend and colleague, covers GW. And we usually sit right next to each other in the office and could be in each other's office very quickly. But I had to ask, "Phil, can you send me your model?" And he had a busy morning as well. And so we weren't able to communicate. I got his model, and I had one of those uh-oh moments. "Uh-oh, Phil's got this asset, great asset, Epidiolex, going generic in 2026." And I don't have him right there, able to grab him and say, "Phil, what's going on here?" But -- so very quickly, and a lot of e
Jazz Pharmaceuticals PLC at Cowen Healthcare Conference (Virtual) Transcript
Mar 02, 2021
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers